The Current Ratio as of December 2025 (TTM) for GeneFerm Biotechnology Co., Ltd. (1796.TWO) is 4.03

According to GeneFerm Biotechnology Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 4.03. This represents a change of 14.40% compared to the average of 3.52 of the last 4 quarters.

GeneFerm Biotechnology Co., Ltd. (1796.TWO) Historical Current Ratio (quarterly & annually)

How has 1796.TWO Current Ratio performed in the past?

The mean historical Current Ratio of GeneFerm Biotechnology Co., Ltd. over the last ten years is 2.27. The current 4.03 Current Ratio has changed 17.68% with respect to the historical average. Over the past ten years (40 quarters), 1796.TWO's Current Ratio was at its highest in in the March 2025 quarter at 4.19. The Current Ratio was at its lowest in in the December 2022 quarter at 0.06.

GeneFerm Biotechnology Co., Ltd. (1796.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of GeneFerm Biotechnology Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

GeneFerm Biotechnology Co., Ltd. (1796.TWO) Average Current Ratio

How has 1796.TWO Current Ratio performed in the past?

The current Current Ratio of GeneFerm Biotechnology Co., Ltd. (1796.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

GeneFerm Biotechnology Co., Ltd. (1796.TWO) Current Ratio vs. Peers

How is 1796.TWO’s Current Ratio compared to its peers?

GeneFerm Biotechnology Co., Ltd.’s Current Ratio is less than LIWANLI Innovation Co., Ltd. (13.30), greater than Winston Medical Supply Co., Ltd. (1.60), less than TSH Biopharm Corporation Limited (4.94), less than InnoPharmax Inc. (6.80), greater than Golden Biotechnology Corporation (0.54), greater than Allied Biotech Corporation (1.51), greater than Crystalvue Medical Corporation (2.56), greater than Sunny Pharmtech Inc. (1.30), greater than BenQ Medical Technology Corporation (1.58), greater than OK Biotech Co., Ltd. (1.81),

Build a custom stock screener for GeneFerm Biotechnology Co., Ltd. (1796.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GeneFerm Biotechnology Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GeneFerm Biotechnology Co., Ltd. (1796.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GeneFerm Biotechnology Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.